カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界の呼吸器用医薬品市場2022年～2026年

■ 英語タイトル：Global Respiratory Drugs Market 2022-2026

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR73197-22）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR73197-22
■ 発行日：2022年4月14日
■ 調査対象地域：北米、ヨーロッパ、アジア太平洋、その他地域
■ 産業分野：医薬品
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の呼吸器用医薬品市場2022年～2026年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

テクナビオ社は、世界の呼吸器用医薬品市場規模が2022年～2026年まで年平均5.96％成長し、269.5億ドルに達すると予測しています。本調査レポートは、呼吸器用医薬品の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別（喘息、COPD、アレルギー性鼻炎、嚢胞性線維症、その他呼吸器疾患）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などを掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の呼吸器用医薬品市場規模：種類別（喘息、COPD、アレルギー性鼻炎、嚢胞性線維症、その他呼吸器疾患）
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Respiratory Drugs Market 2022-2026
Technavio has been monitoring the respiratory drugs market and it is poised to grow by $ 26.95 bn during 2022-2026 progressing at a CAGR of 5.96% during the forecast period. Our report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the need for sustainable and safe respiratory drugs, an increase in incidence and prevalence of respiratory disorders, and an increase in patient awareness.
The respiratory drugs market analysis includes type segment and geographic landscape.

Technavio’s respiratory drugs market is segmented as below:

By Type
• Asthma
• COPD
• Allergic rhinitis
• Cystic fibrosis
• Other respiratory diseases

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the high cost of respiratory disease management as one of the prime reasons driving the respiratory drugs market growth during the next few years. Also, the availability of biologics and biosimilars, and the high use of complementary and alternative medicines will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the respiratory drugs market covers the following areas:
• Respiratory drugs market sizing
• Respiratory drugs market forecast
• Respiratory drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aerogen Pharma Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Celon Pharma SA, Cipla Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Laboratory Corp. of America Holdings, Lupin Ltd., Medisol Lifescience Pvt. Ltd., Merck and Co. Inc., Novartis AG, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., and Wellona Pharma. Also, the respiratory drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/respiratory-drugs-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type – Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Asthma – Market size and forecast 2021-2026
o Exhibit 28: Chart on Asthma – Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Asthma – Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Asthma – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Asthma – Year-over-year growth 2021-2026 (%)
o 5.4 COPD – Market size and forecast 2021-2026
o Exhibit 32: Chart on COPD – Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on COPD – Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on COPD – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on COPD – Year-over-year growth 2021-2026 (%)
o 5.5 Allergic rhinitis – Market size and forecast 2021-2026
o Exhibit 36: Chart on Allergic rhinitis – Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Allergic rhinitis – Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Allergic rhinitis – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Allergic rhinitis – Year-over-year growth 2021-2026 (%)
o 5.6 Cystic fibrosis – Market size and forecast 2021-2026
o Exhibit 40: Chart on Cystic fibrosis – Market size and forecast 2021-2026 ($ billion)
o Exhibit 41: Data Table on Cystic fibrosis – Market size and forecast 2021-2026 ($ billion)
o Exhibit 42: Chart on Cystic fibrosis – Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Cystic fibrosis – Year-over-year growth 2021-2026 (%)
o 5.7 Other respiratory diseases – Market size and forecast 2021-2026
o Exhibit 44: Chart on Other respiratory diseases – Market size and forecast 2021-2026 ($ billion)
o Exhibit 45: Data Table on Other respiratory diseases – Market size and forecast 2021-2026 ($ billion)
o Exhibit 46: Chart on Other respiratory diseases – Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Other respiratory diseases – Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Type
o Exhibit 48: Market opportunity by Type ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 54: Chart on North America – Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on North America – Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia – Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 70: Chart on US – Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on US – Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 UK – Market size and forecast 2021-2026
o Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.10 China – Market size and forecast 2021-2026
o Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ billion)
o Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ billion)
o Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.11 Canada – Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada – Market size and forecast 2021-2026 ($ billion)
o Exhibit 87: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)
o Exhibit 88: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories – Overview
o Exhibit 98: Abbott Laboratories – Business segments
o Exhibit 99: Abbott Laboratories – Key news
o Exhibit 100: Abbott Laboratories – Key offerings
o Exhibit 101: Abbott Laboratories – Segment focus
o 10.4 AstraZeneca Plc
o Exhibit 102: AstraZeneca Plc – Overview
o Exhibit 103: AstraZeneca Plc – Product / Service
o Exhibit 104: AstraZeneca Plc – Key news
o Exhibit 105: AstraZeneca Plc – Key offerings
o 10.5 Boehringer Ingelheim International GmbH
o Exhibit 106: Boehringer Ingelheim International GmbH – Overview
o Exhibit 107: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 108: Boehringer Ingelheim International GmbH – Key news
o Exhibit 109: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 110: Boehringer Ingelheim International GmbH – Segment focus
o 10.6 Celon Pharma SA
o Exhibit 111: Celon Pharma SA – Overview
o Exhibit 112: Celon Pharma SA – Business segments
o Exhibit 113: Celon Pharma SA – Key offerings
o Exhibit 114: Celon Pharma SA – Segment focus
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 115: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 116: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 117: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 118: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 119: F. Hoffmann La Roche Ltd. – Segment focus
o 10.8 GlaxoSmithKline Plc
o Exhibit 120: GlaxoSmithKline Plc – Overview
o Exhibit 121: GlaxoSmithKline Plc – Business segments
o Exhibit 122: GlaxoSmithKline Plc – Key news
o Exhibit 123: GlaxoSmithKline Plc – Key offerings
o Exhibit 124: GlaxoSmithKline Plc – Segment focus
o 10.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 125: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 126: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 127: Glenmark Pharmaceuticals Ltd. – Key offerings
o 10.10 Novartis AG
o Exhibit 128: Novartis AG – Overview
o Exhibit 129: Novartis AG – Business segments
o Exhibit 130: Novartis AG – Key offerings
o Exhibit 131: Novartis AG – Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 132: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 133: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 134: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 135: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 136: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 Vertex Pharmaceuticals Inc.
o Exhibit 137: Vertex Pharmaceuticals Inc. – Overview
o Exhibit 138: Vertex Pharmaceuticals Inc. – Product / Service
o Exhibit 139: Vertex Pharmaceuticals Inc. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 140: Inclusions checklist
o Exhibit 141: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 142: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 143: Research methodology
o Exhibit 144: Validation techniques employed for market sizing
o Exhibit 145: Information sources
o 11.5 List of abbreviations
o Exhibit 146: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Asthma – Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Asthma – Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Asthma – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Asthma – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on COPD – Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on COPD – Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on COPD – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on COPD – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Allergic rhinitis – Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Allergic rhinitis – Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Allergic rhinitis – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Allergic rhinitis – Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Cystic fibrosis – Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Cystic fibrosis – Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Cystic fibrosis – Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Cystic fibrosis – Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Other respiratory diseases – Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Other respiratory diseases – Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Other respiratory diseases – Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Other respiratory diseases – Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America – Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America – Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe – Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia – Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US – Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US – Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany – Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK – Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on UK – Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China – Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on China – Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada – Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories – Overview
Exhibits98: Abbott Laboratories – Business segments
Exhibits99: Abbott Laboratories – Key news
Exhibits100: Abbott Laboratories – Key offerings
Exhibits101: Abbott Laboratories – Segment focus
Exhibits102: AstraZeneca Plc – Overview
Exhibits103: AstraZeneca Plc – Product / Service
Exhibits104: AstraZeneca Plc – Key news
Exhibits105: AstraZeneca Plc – Key offerings
Exhibits106: Boehringer Ingelheim International GmbH – Overview
Exhibits107: Boehringer Ingelheim International GmbH – Business segments
Exhibits108: Boehringer Ingelheim International GmbH – Key news
Exhibits109: Boehringer Ingelheim International GmbH – Key offerings
Exhibits110: Boehringer Ingelheim International GmbH – Segment focus
Exhibits111: Celon Pharma SA – Overview
Exhibits112: Celon Pharma SA – Business segments
Exhibits113: Celon Pharma SA – Key offerings
Exhibits114: Celon Pharma SA – Segment focus
Exhibits115: F. Hoffmann La Roche Ltd. – Overview
Exhibits116: F. Hoffmann La Roche Ltd. – Business segments
Exhibits117: F. Hoffmann La Roche Ltd. – Key news
Exhibits118: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits119: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits120: GlaxoSmithKline Plc – Overview
Exhibits121: GlaxoSmithKline Plc – Business segments
Exhibits122: GlaxoSmithKline Plc – Key news
Exhibits123: GlaxoSmithKline Plc – Key offerings
Exhibits124: GlaxoSmithKline Plc – Segment focus
Exhibits125: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits126: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits127: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits128: Novartis AG – Overview
Exhibits129: Novartis AG – Business segments
Exhibits130: Novartis AG – Key offerings
Exhibits131: Novartis AG – Segment focus
Exhibits132: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits133: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits134: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits135: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits136: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits137: Vertex Pharmaceuticals Inc. – Overview
Exhibits138: Vertex Pharmaceuticals Inc. – Product / Service
Exhibits139: Vertex Pharmaceuticals Inc. – Key offerings
Exhibits140: Inclusions checklist
Exhibits141: Exclusions checklist
Exhibits142: Currency conversion rates for US$
Exhibits143: Research methodology
Exhibits144: Validation techniques employed for market sizing
Exhibits145: Information sources
Exhibits146: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の商用車用フリートマネジメントシステム市場2022年～2026年
  • 世界の埋め込み型医療機器市場2022年～2026年
  • 世界のフレキシブルディスプレイ市場2022年～2026年
  • 世界の菓子市場2022年～2026年
  • 世界の代替燃料市場2022年～2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR73197-22 )"世界の呼吸器用医薬品市場2022年～2026年" (英文：Global Respiratory Drugs Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。